Semi-permeable Microcapsules for Single-Cell Nucleic Acid Barcoding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current droplet-based microfluidics for single-cell nucleic acid barcoding face challenges such as difficulty in replacing or removing reagents, incompatibility with harsh lysis conditions, and suboptimal reaction yields due to inhibitory compounds.
Innovation Solution
The method involves co-encapsulating semi-permeable microcapsules carrying nucleic acid lysates and particles with molecular tags into microfluidic droplets, allowing for efficient cell lysis under harsh conditions and subsequent barcoding of nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If harsh lysis reagents (SDS, guanidinium chloride) are used to improve cell lysis efficiency, then cell lysis is enhanced, but the reagents become incompatible with RT and PCR assays
Solution Approach 1:
The system divides the reaction environment into two segments: water-in-oil droplets for enzymatic reactions (RT and PCR) and oil-in-water droplets for harsh lysis conditions. This spatial segmentation allows each process to occur in its optimal environment without mutual interference, resolving the contradiction between lysis efficiency and assay compatibility
Solution Approach 2:
The patent introduces an intermediary emulsion system (double emulsion structure) that mediates between the harsh lysis reagents and the sensitive enzymatic reactions. The emulsion interfaces and phase separation act as intermediaries that allow efficient lysis while protecting the subsequent RT and PCR reactions from inhibitor contamination
2Manufacturing precision
If cells are encapsulated in water-in-oil droplets for droplet microfluidics, then single-cell isolation is achieved, but removing or replacing reagents inside the compartments becomes challenging
Solution Approach 1:
The system employs dynamic emulsion structures (water-in-oil-in-water double emulsions) that can transition between stable encapsulation and controlled release states. This dynamic property allows the droplets to maintain single-cell isolation while enabling reagent exchange through controlled interface manipulation and phase transitions
Solution Approach 2:
The patent utilizes phase transitions in the emulsion system to facilitate reagent removal and replacement. By controlling the phase state of the emulsion droplets, the system can transition from a stable encapsulated state to a state where reagents can be exchanged, then back to stable encapsulation, enabling easy operation while maintaining precision
3Adaptability or versatility
If mild lysis conditions are used to maintain compatibility with RT and PCR assays, then assay compatibility is improved, but cell lysis efficiency becomes suboptimal leading to lower reaction yields
Solution Approach 1:
The reaction system is segmented into distinct droplet phases where harsh lysis occurs in one phase (oil-in-water) while RT and PCR occur in another phase (water-in-oil). This segmentation allows mild conditions in the enzymatic reaction phase to preserve assay compatibility while the separate lysis phase achieves efficient cell breakdown, ultimately improving both compatibility and yield
Solution Approach 2:
Cell lysis is performed as a preliminary action in a separate emulsion phase before the nucleic acid extraction and enzymatic reaction steps. This preliminary lysis action completes cell breakdown under optimal harsh conditions, then the system transitions to the gentle enzymatic reaction phase, ensuring both efficient lysis and high assay compatibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables improved cell lysis, nucleic acid purification, and removal of inhibitory compounds, leading to enhanced barcoding reaction efficiency and precise labeling of nucleic acids from individual cells.
Implementation Method 1
a microcapsule comprising a semi-permeable shell and a core
Implementation Method 2
co-encapsulating a microcapsule and a particle in a droplet
Data Source
AI summary
The present invention concerns a method comprising co-encapsulating a microcapsule and a particle in a droplet, the microcapsule comprising a semi-permeable shell and a core, wherein the core comprises a nucleic acid for processing, and wherein the particle comprises a reagent for use in the processing of the nucleic acid.